OmniGraf® Liver is the first non-invasive blood test that offers clinicians the ability to rule out subclinical acute rejection, confirming that the current immunosuppressive regimen is adequately suppressing the immune system, confirming the immune system is in a state of quiescence.
18% of all liver transplant recipients, living – DCD – DBD, suffer silent rejection.
We work on exclusive basis with BioHope of Spain and Eurofin of the US.
Our customers are the pillars of our strength and motivation to strive for a better tomorrow.
Utilized machine on more than 10 marginal organs (both liver and kidney). Vitasmart benefits lots of patients by transplanting them with Marginal organs which otherwise would have been discarded
There are very less incidences of DGF, PNF and low rejection rates compared to static cold storage
Extended criteria organs were allocated to the patients benefited with shorter hospital stay
Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts.
Even the all-powerful Pointing has no control about the blind texts it is an almost unorthographic life One day however a small line of blind text by the name of Lorem Ipsum decided to leave for the far World of Grammar.
To learn more about Duraent's innovative organ preservation solutions and transplant technologies, contact us. Discover how we empower medical professionals to deliver life-saving results through groundbreaking products like VitaSmart™ and Belzer UW® Cold Storage Solution.
